News
Stelis Biopharma appoints Mark W. Womack as the new CEO
Stelis Biopharma Limited (Stelis or Company), a vertically integrated biopharma and vaccines Company and the biotech arm of Strides Pharma Science Limited, announced the appointment of Mark W. Womack (Mark) as the new Chief Executive Officer (CEO).
Mark is also the Managing...
News
Virus Safety in Continuous Processes
Virus safety is a key element in biopharmaceutical manufacturing. Inherently, animal cell culture involves risks related to virus safety. Chinese Hamster Ovary (CHO) cell lines are the most common production platform for expressing glycosylated proteins and monoclonal antibodies. Being...
Clinical Trials
Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate
Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced positive topline results from the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate,...
News
What Is Gene Therapy? How Does It Save and Improve the Quality of Life?
What Is Gene Therapy?
Gene therapy is a new and exciting technique, defined as the use of genetic material to cure or alleviate disease. It is considered revolutionary, yet still in its infancy, with many new therapies currently undergoing clinical trials.
Gene...
News
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility
Emergent BioSolutions Inc. announced that the U.S. FDA is allowing Emergent’s Bayview manufacturing facility to resume production of Johnson & Johnson’s (J&J) Covid-19 vaccine bulk drug substance. This resumption of manufacturing follows extensive reviews by FDA, weeks of diligent...
Clinical Trials
Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
Eli Lilly and Company and Incyte announced results from an additional cohort of 101 adult patients from the COV-BARRIER trial. In this sub-study, patients with COVID-19 on mechanical ventilation or extracorporeal membrane oxygenation (ECMO) who received baricitinib plus standard...
News
Clarivate Acquires Bioinfogate, Reinforcing Position as Premier Provider of End-to-End Research Intelligence Solutions for Life Sciences
Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the OFF-X™ portal. Financial terms...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















